Clinical Trial Update: Flexibly adding-on Second Antimuscarinic Agent to the First Antimuscarinics for Refractory Overactive Bladder Syndrome [Phase 4]

View source ↗

Summary

This clinical trial update reports the completion of a Phase 4 study evaluating the flexible addition of a second antimuscarinic agent to a first antimuscarinic…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Overactive Bladder

Snippet

Sponsor: Buddhist Tzu Chi General Hospital | Conditions: Overactive Bladder | Phase 4 | Status: COMPLETED